Taysha Gene Therapies Inc [NASDAQ: TSHA] traded at a low on Monday, posting a -4.94 loss after which it closed the day’ session at $3.08.
The results of the trading session contributed to over 4788147 shares changing hands. Over the past one week, the price volatility of Taysha Gene Therapies Inc stands at 11.22% while the volatility over the past one month is 14.33%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for TSHA stock reached $681.73 million, with 204.94 million shares outstanding and 153.61 million shares in the current float. Compared to the average trading volume of 3.73M shares, TSHA reached a trading volume of 4788147 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Taysha Gene Therapies Inc [TSHA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TSHA shares is $6.59 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TSHA stock is a recommendation set at 1.09. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BMO Capital Markets have made an estimate for Taysha Gene Therapies Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 27, 2024. While these analysts kept the previous recommendation, Piper Sandler raised their target price to Overweight. The new note on the price target was released on April 09, 2024, representing the official price target for Taysha Gene Therapies Inc stock. Previously, the target price had yet another drop from $14 to $1.50, while Jefferies kept a Hold rating on TSHA stock. On January 27, 2023, analysts decreased their price target for TSHA shares from 23 to 3.
The Average True Range (ATR) for Taysha Gene Therapies Inc is set at 0.27, with the Price to Sales ratio for TSHA stock in the period of the last 12 months amounting to 68.79. The Price to Book ratio for the last quarter was 7.11, with the Price to Cash per share for the same quarter was set at 0.71.
How has TSHA stock performed recently?
Taysha Gene Therapies Inc [TSHA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 24.70. With this latest performance, TSHA shares gained by 82.25% in over the last four-week period, additionally sinking by -14.92% over the last 6 months – not to mention a rise of 75.00% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TSHA stock in for the last two-week period is set at 68.70, with the RSI for the last a single of trading hit 71.30, and the three-weeks RSI is set at 66.09 for Taysha Gene Therapies Inc [TSHA]. The present Moving Average for the last 50 days of trading for this stock 2.06, while it was recorded at 3.03 for the last single week of trading, and 2.45 for the last 200 days.
Taysha Gene Therapies Inc [TSHA]: Deeper insight into the fundamentals
Taysha Gene Therapies Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.51 and a Current Ratio set at 5.51.
Insider trade positions for Taysha Gene Therapies Inc [TSHA]
There are presently around $77.46%, or 93.93%% of TSHA stock, in the hands of institutional investors. The top three institutional holders of TSHA stocks are: FMR LLC with ownership of 21.21 million shares, which is approximately 9.1722%. RTW INVESTMENTS, LP, holding 18.8 million shares of the stock with an approximate value of $$42.11 million in TSHA stocks shares; and RTW INVESTMENTS, LP, currently with $$41.78 million in TSHA stock with ownership which is approximately 8.0649%.
